DE60017229D1 - DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen - Google Patents

DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen

Info

Publication number
DE60017229D1
DE60017229D1 DE60017229T DE60017229T DE60017229D1 DE 60017229 D1 DE60017229 D1 DE 60017229D1 DE 60017229 T DE60017229 T DE 60017229T DE 60017229 T DE60017229 T DE 60017229T DE 60017229 D1 DE60017229 D1 DE 60017229D1
Authority
DE
Germany
Prior art keywords
structural protein
dna encoding
infectious salmon
anemia virus
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60017229T
Other languages
English (en)
Inventor
Erik Biering
Bjorn Krossoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60017229(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60017229D1 publication Critical patent/DE60017229D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60017229T 1999-10-18 2000-10-12 DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen Expired - Lifetime DE60017229D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (1)

Publication Number Publication Date
DE60017229D1 true DE60017229D1 (de) 2005-02-10

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017229T Expired - Lifetime DE60017229D1 (de) 1999-10-18 2000-10-12 DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen

Country Status (10)

Country Link
US (1) US6471964B1 (de)
EP (1) EP1094069B2 (de)
JP (1) JP4777508B2 (de)
AT (1) ATE286507T1 (de)
AU (1) AU778791B2 (de)
CA (1) CA2321437A1 (de)
DE (1) DE60017229D1 (de)
DK (1) DK1094069T4 (de)
NO (1) NO330866B1 (de)
NZ (1) NZ507530A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332712T1 (de) * 1999-08-07 2006-08-15 Novartis Pharma Gmbh Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
CA2402339C (en) * 2000-03-08 2010-01-12 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
DE60239753D1 (de) 2001-10-19 2011-05-26 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
JP2010514412A (ja) 2006-12-22 2010-05-06 ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ Ｄｎａ魚ワクチン
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59610384D1 (de) * 1995-10-18 2003-05-28 Bayer Cropscience Ag Iminoessigsäureamide und ihre verwendung als schädlingsbekämpfungsmittel
PT839913E (pt) * 1996-11-04 2006-09-29 Ottawa Health Research Inst Metodo de expressao de polipeptidos em peixe por imerssao numa solucao de adn plasmidico
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
ATE332712T1 (de) * 1999-08-07 2006-08-15 Novartis Pharma Gmbh Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Also Published As

Publication number Publication date
NO20005217L (no) 2001-04-19
JP2001211888A (ja) 2001-08-07
DK1094069T4 (da) 2008-07-21
EP1094069B2 (de) 2008-04-23
AU778791B2 (en) 2004-12-23
AU6653800A (en) 2001-04-26
NO330866B1 (no) 2011-08-01
NZ507530A (en) 2001-08-31
NO20005217D0 (no) 2000-10-17
EP1094069A1 (de) 2001-04-25
US6471964B1 (en) 2002-10-29
EP1094069B1 (de) 2005-01-05
CA2321437A1 (en) 2001-04-18
ATE286507T1 (de) 2005-01-15
DK1094069T3 (da) 2005-05-17
JP4777508B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
DE60043299D1 (de) Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
DE60017229D1 (de) DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
PT1219711E (pt) Vacina de lawsonia intracellularis
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
ATE235553T1 (de) Protein p100von menschlichem herpesvirus typ 6, die korrespondierenden dns squenzen, ihre herstellung und verwendung
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
WO2002036733A3 (en) Cd36 as a heat shock protein receptor and uses thereof
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
ATE368117T1 (de) Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung
Zrein et al. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
WO2000022134A3 (de) Testkit zur diagnose von borreliosen und neue borrelia-antigene für die impfstoffentwicklung
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)
TH98990B (th) ไคเมอริกไวรัสซึ่งแสดงโปรตีนพื้นผิวแบบไม่ใช่โปรตีนธรรมชาติและการใช้ไคเมอริกไวรัสเหล่านี้

Legal Events

Date Code Title Description
8332 No legal effect for de